Large-scale testing (Phase 3)Ended earlyNCT02809118
What this trial is testing
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Who this might be right for
Hearing Loss, Idiopathic Sudden Sensorineural
Auris Medical, Inc. 56